Vas Narasimhan

Jump to

‘Indian-origin CEOs take pride in identity’: Novartis’s Vas Narasimhan

In an exclusive interview with CNBC-TV18, Novartis top boss Vas Narasimhan spoke about the rise and rise of Indian-origin CEOs.
Coronavirus pandemic | Novartis CEO warns of second COVID-19 wave

While the pace of new infections is likely to slow down in Italy and Spain, a massive surge in numbers is expected in the United States, Vasant Narasimhan said
Starting to design clinical studies in India: Novartis

Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.
Govt needs to be a strong enabler in pharma sector: Experts

Shereen Bhan speaks with top bosses from the pharma sector along with KT Rama Rao, Minister of IT, Telangana at Bioasia 2017 to discuss way forward for pharma sector in making India healthier.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Vas Narasimhan

‘Indian-origin CEOs take pride in identity’: Novartis’s Vas Narasimhan

Coronavirus pandemic | Novartis CEO warns of second COVID-19 wave

Starting to design clinical studies in India: Novartis

Govt needs to be a strong enabler in pharma sector: Experts